Stock Analysis on Net
Stock Analysis on Net

Abbott Laboratories (NYSE:ABT)

Common-Size Balance Sheet: Liabilities and Stockholders’ Equity 

Abbott Laboratories, common-size consolidated balance sheet: liabilities and stockholders’ equity

Microsoft Excel
Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021 Dec 31, 2020
Short-term borrowings 0.00 0.00 0.00 0.00 0.29
Trade accounts payable 5.15 5.87 6.19 5.86 5.44
Salaries, wages and commissions 2.09 2.18 2.09 2.16 1.95
Accrued rebates payable to government agencies 0.76 0.89 0.86 0.48 0.44
Accrued other rebates 1.35 1.49 1.46 1.44 1.11
All other 4.21 5.03 5.53 4.97 5.57
Other accrued liabilities 6.32% 7.41% 7.85% 6.89% 7.12%
Dividends payable 1.26 1.30 1.19 1.11 1.10
Income taxes payable 0.73 0.67 0.46 0.41 0.50
Current portion of long-term debt 1.84 1.48 3.02 1.00 0.01
Current liabilities 17.39% 18.90% 20.81% 17.43% 16.41%
Long-term debt, excluding current portion 15.51 18.57 19.51 23.00 25.54
Defined benefit pension plans and post-employment medical and dental plans for significant plans 2.31 2.68 2.40 3.64 4.30
Deferred income taxes 0.63 0.78 1.33 1.85 1.94
Operating lease liability, non-current 1.10 1.30 1.27 1.27 1.24
All other 4.23 4.73 5.11 4.90 5.08
Post-employment obligations and other long-term liabilities 8.27% 9.49% 10.11% 11.66% 12.56%
Long-term liabilities 23.77% 28.06% 29.61% 34.67% 38.10%
Total liabilities 41.16% 46.97% 50.42% 52.09% 54.51%
Preferred shares, one dollar par value, none issued 0.00 0.00 0.00 0.00 0.00
Common shares, without par value 30.90 33.97 33.19 32.54 33.28
Common shares held in treasury, at cost -20.69 -21.83 -20.46 -15.72 -13.84
Earnings employed in the business 58.05 51.29 47.36 41.93 38.08
Accumulated other comprehensive loss -9.71 -10.71 -10.82 -11.14 -12.33
Total Abbott shareholders’ investment 58.55% 52.73% 49.28% 47.61% 45.19%
Noncontrolling interests in subsidiaries 0.29 0.31 0.29 0.30 0.30
Total shareholders’ investment 58.84% 53.03% 49.58% 47.91% 45.49%
Total liabilities and shareholders’ investment 100.00% 100.00% 100.00% 100.00% 100.00%

Based on: 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31).

Short-term borrowings
The data for short-term borrowings is only available for 2020, representing a minimal 0.29% of total liabilities and shareholders’ investment. No subsequent data is provided to analyze trend development.
Trade accounts payable
Trade accounts payable displayed a gradual increase from 5.44% in 2020 to a peak of 6.19% in 2022, followed by a decline to 5.15% in 2024. This suggests fluctuating payment obligations with a tendency to normalize in recent years.
Salaries, wages and commissions
These costs increased from 1.95% in 2020 to 2.18% in 2023, before slightly receding to 2.09% in 2024, indicating relatively stable labor-related expenses as a portion of total liabilities and shareholders’ investment.
Accrued rebates payable to government agencies
Accrued rebates saw a marked rise from 0.44% in 2020 to 0.89% in 2023, then declined to 0.76% in 2024, demonstrating increased short-term liabilities related to governmental rebate obligations which moderated recently.
Accrued other rebates
This item gradually increased from 1.11% in 2020 to a plateau around 1.49% in 2023, dropping slightly to 1.35% in 2024, suggesting stable liabilities related to accruals other than government rebates.
All other (current liabilities)
The 'All other' category within current liabilities decreased from 5.57% in 2020 to 4.21% in 2024, indicating a reduction in miscellaneous short-term liabilities over the period.
Other accrued liabilities
Other accrued liabilities fluctuated mildly, peaking at 7.85% in 2022 before falling to 6.32% in 2024, suggesting some volatility but a general downward trend in accrued short-term obligations.
Dividends payable
Dividends payable showed a slight upward trend from 1.10% in 2020 to 1.30% in 2023, with a minor decrease to 1.26% in 2024, reflecting relatively stable dividend liabilities.
Income taxes payable
Income taxes payable decreased initially from 0.50% in 2020 to 0.41% in 2021 but then increased to 0.73% by 2024, highlighting a rising tax liability position in recent years.
Current portion of long-term debt
This liability rose significantly from 0.01% in 2020 to 3.02% in 2022, then declined to 1.84% in 2024, indicating variation in near-term debt maturities impacting current liabilities.
Current liabilities (aggregate)
Current liabilities as a whole rose from 16.41% in 2020 to a peak of 20.81% in 2022, then decreased to 17.39% in 2024, showing an overall moderate increase with some normalization after mid-period elevation.
Long-term debt excluding current portion
There was a steady decline in long-term debt from 25.54% in 2020 to 15.51% in 2024, suggesting efforts to reduce longer-term financial leverage.
Defined benefit pension plans and post-employment medical and dental plans
This category dropped from 4.30% in 2020 to 2.31% in 2024, reflecting a consistent reduction in long-term post-employment benefit obligations.
Deferred income taxes
Deferred income taxes declined significantly from 1.94% in 2020 to 0.63% in 2024, indicating decreasing future tax liabilities accounted for on the balance sheet.
Operating lease liability, non-current
Non-current operating lease liabilities remained relatively stable, around 1.10%-1.30%, with a slight decline to 1.10% in 2024.
All other (long-term liabilities)
The 'All other' category for long-term liabilities moderately declined from 5.08% in 2020 to 4.23% in 2024, indicating small reductions in miscellaneous long-term obligations.
Post-employment obligations and other long-term liabilities
These obligations decreased steadily from 12.56% in 2020 to 8.27% in 2024, reinforcing the trend of lowering pension and similar liabilities.
Long-term liabilities (total)
Overall long-term liabilities declined notably from 38.10% in 2020 to 23.77% in 2024, representing a material lowering of the company’s long-term financial burdens.
Total liabilities
Total liabilities decreased from 54.51% in 2020 to 41.16% in 2024, indicating a significant reduction in total obligations relative to the combined total of liabilities and shareholders’ investment.
Common shares without par value
The proportion of common shares remained fairly stable around 30.90%-33.97%, with a slight dip to 30.90% in 2024.
Common shares held in treasury, at cost
Treasury shares increased in absolute negative value from -13.84% in 2020 to -21.83% in 2023 and then slightly rebounded to -20.69% in 2024, showing significant treasury stock repurchases and holdings.
Earnings employed in the business
Earnings retained in the business showed a consistent and strong increase from 38.08% in 2020 to 58.05% in 2024, highlighting growth in accumulated earnings and reinvestment capacity.
Accumulated other comprehensive loss
The comprehensive loss decreased steadily from -12.33% in 2020 to -9.71% in 2024, reflecting an improvement in other comprehensive income components affecting shareholders' equity.
Total Abbott shareholders’ investment
Shareholders’ investment increased steadily from 45.19% in 2020 to 58.55% in 2024, coinciding with the reduction of liabilities and growth in earnings reinvested.
Noncontrolling interests in subsidiaries
Noncontrolling interests remained relatively constant, fluctuating narrowly around 0.29%-0.31%, indicating stable minority interest holdings.
Total shareholders’ investment (aggregate)
Overall shareholders’ equity grew substantially from 45.49% in 2020 to 58.84% in 2024, reflecting strengthening financial position through increased equity and reduced leverage.
Total liabilities and shareholders’ investment
The sum consistently equals 100%, confirming the proportional distribution over time without data omissions.